Brisbane. Australia’s Vaccine and Biologics Hub
A Center of Excellence for Vaccines, Biologics, and Clinical Pharmacology.
Strategically located within the Royal Brisbane and Women’s Hospital, our Brisbane facility specializes in early-phase trials requiring high-volume participant and outpatient requirements, robust oversight, and complex pharmacology expertise.
Purpose-built for complex, high-throughput trials
Nucleus Network Brisbane is Australia’s second-largest early-phase clinical trials unit, known for excellence in vaccine and biologic studies. It is co-located with the Royal Brisbane and Women’s Hospital, the site provides immediate access to emergency care, imaging, and laboratory services, supporting safe, rapid, and scalable trial execution.
Our Brisbane team has deep experience across high-throughput clinical pharmacology trials, including First-in-Human, healthy volunteer, and early patient cohorts.
Fast facts
61
Beds
Royal Brisbane and Women’s Hospital & Agilex Biolabs
Co-Location
Vaccines, biologics, DDI, metabolic disorders
Therapeutic Expertise
FIH, SAD/MAD, bioavailability/bioequivalence,DDI, vaccine, challenge models
Study Types
TGA, FDA and EMA-ready standards
Certifications
300k+ national database
Participant Access
Why Brisbane?
High-Performance Trial Delivery in a Hospital-Grade Setting
- Located within a major tertiary health precinct
- Strong enrolment capacity for large or seasonal cohorts (e.g. vaccines)
- Dedicated First-in-Human and early phase medical teams with 24/7 oversight
- Real-time data handling, including onsite labs and central pharmacy access
- Co-located with Agilex Biolabs allowing time-sensitive sample processing techniques in the same building as clinical trial participants
- Rapid ethics and CTN startup, studies can begin dosing in 6–8 weeks from protocol receipt*
- Eligible for Australia’s 43.5% R&D tax incentive*
Focused experience across core early-phase areas
- Vaccines & Infectious Diseases (including challenge trials)
- Radiology
- Dermatology
- Metabolic & endocrine (e.g. diabetes, obesity)
- Opthalmology
- Respiratory
- Healthy volunteer studies and special populations
- Cardiology QT/QTc assessments
What sponsors can expect at our Brisbane site
- High-volume screening and dosing capability
- Integrated marketing and call centre for participant recruitment
- Access to local specialists for protocol-specific assessments
- 24/7 medical coverage and emergency access via co-located hospital
- FDA- and EMA-compliant SOPs across all functions
- Supported by unified systems across our Melbourne and Minneapolis sites
Ready to launch your next study in Brisbane
Whether you’re developing a biologic, planning a large vaccine study, or seeking a fast First-in-Human launch, Nucleus Network Brisbane delivers with speed, safety, and scale.
